Using a new vaccine method, certain virus genes can be injected in the form of their RNA. They then stimulate the body’s cells to produce...

Several research groups at Columbia University Irving Medical Center and the School of Engineering and Applied Sciences have projects...

INO-4800 is a DNA vaccine candidate matched to the novel coronavirus SARS-CoV-2, which causes the COVID-19 disease in humans. Inovio's...

We are rapidly developing human neutralizing monoclonal antibodies for SARS-CoV-2. We need funds or services in kind for manufacture and...

Scientists at MIGAL Research Institute in Israel expect to start producing a Covid-19 vaccine in the next eight-ten weeks, based on their...

Algernon is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them...

Our team has a prototype of a low-cost, easy-to-use ventilator that is optimized for emergency and mass casualty scenarios. The team is...

A University of British Columbia investigator led an international team that has discovered an experimental drug that effectively blocks...

TJM2 is an internally discovered neutralizing antibody against human GM-CSF, an important cytokine that plays a critical role in chronic...

Professor Robin Shattock and his team in Imperial College London’s Department of Infectious Disease developed a candidate vaccine within...

Chinese medical research institution in Beijing, Institute of Materia Medica, Chinese Academy of Medical Sciences, enters a strategic...

Roche has announced that the US Food and Drug Administration (FDA) has formally approved its phase 3 trial of Actemra in severely ill...

Researchers have revealed they will be trialling an inhaled drug named SNG001 in 100 COVID-19 patients to see if the interferon beta 1a...

Takeda is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with...

CEPI, the Coalition for Epidemic Preparedness Innovations, today added an eighth COVID-19 vaccine candidate to its portfolio. CEPI will...

Ad5-nCoV is the first novel coronavirus vaccine for COVID-19 in a Phase 1 Clinical Trial in China. The vaccine candidate is built upon...

TNX-1800 (live modified horsepox virus vaccine) is being developed by Tonix Pharmaceuticals in a strategic collaboration with Southern...

OyaGen is focused on the identification and early development of novel therapeutics for the treatment of viral diseases including HIV,...

BNT162 is a vaccine candidate based upon mRNA. The four vaccine candidates are the first candidates from BioNTech’s COVID-19-focused...

Researchers worldwide are trying to develop a vaccine and antiviral treatments against the new corona virus spreading in China. At...

Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine...

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation...

Arcturus Therapeutics, a leading messenger RNA medicines company, and Duke-NUS Medical School (Duke-NUS), a research intensive, graduate...

A team of researchers at the University of Georgia are developing and testing new vaccines and immunotherapies to combat the novel...

Innovation is evaluating Brilacidin, under Fast Track designation, in a Phase 2 clinical trial as an oral rinse to attenuate Oral...

Canada announced $23.3 million in total support for the University of Saskatchewan's (USask) Vaccine and Infectious Disease Organization...

HKU has joined a global effort to develop a vaccine candidate against COVID-19, led the Coalition for Epidemic Preparedness Innovations...

The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new...

AI company Gero has reviewed the existing drugs and other agents tested on humans and found potential coronavirus treatments. The list of...

The World Health Organization has indicated that it will be approximately 18 months before a vaccine for COVID-19 is developed. Using our...

BeyondSpring Inc. recently announced the submission of a provisional US patent application for its pipeline asset BPI-002, for methods of...

The Indian Council of Medical Research (ICMR) has confirmed that India will be part of the solidarity trials being conducted by the WHO...

“We plan to leverage Heat Biologics’ proprietary vaccine platform to stimulate T-cell immune responses, which play a crucial role in...

Blood samples fromdays 0, 3, and 7demonstrated that leronlimab induced significant reductions in the cytokine storm among all 7 severely...

AmnioBoost has potential for use in the treatment of ARDS, which is the principal cause of death in COVID-19 infection. Mortality in...

This nucleoside RNA polymerase inhibitor disrupts the viral replication process and has the potential to fight multiple viral threats...

Novavax, Inc. recently announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19...

Based on recent clinical data from studies in China with another IL-6 inhibitor, we believe there is a potential role for Kevzara®...

Founded in 2010, Moderna uses messenger RNA, which carries genetic information from DNA to ribosomes to produce proteins. Moderna hijacks...

We have developed a replication-deficient simian adenoviral vector vaccine expressing the SARS-CoV-2 surface Spike protein...

Tiziania is developing a fully human monoclonal antibody (mAb) targeting the receptor for IL-6. This asset was in-licensed from Novimmune...

An expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and immunology at the Icahn School...